Science Explorer Interactive view Map
Company · Shanghai · China

Sanofi (China)

sanofi.cn/l/cn/zh/index.jspROR OpenAlex
Research works
92
▲ 55% vs 2013–17
Citations
784
8.5 per fractional work
Top-10% rate
12.6%
record average 16.5%
Open access
52%
world 28%

Not ranked overall: Sanofi (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.27× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.83× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 2.82× its world share, 1 worksImmunology and Micro…Neuroscience: 0.76× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.97× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 0.65× its world share, 0 worksChemical EngineeringChemistry: 0.03× its world share, 0 worksChemistryComputer Science: 0.44× its world share, 1 worksComputer ScienceEngineering: 0.08× its world share, 0 worksEngineeringEnvironmental Science: 0.68× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.07× its world share, 0 worksMaterials ScienceMathematics: 2.78× its world share, 1 worksMathematicsHealth Professions: 0.12× its world share, 0 worksHealth ProfessionsMedicine: 3.67× its world share, 26 worksMedicineNursing: 0.12× its world share, 0 worksNursingDecision Sciences: 0.51× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.22× its world share, 0 worksEconomics, Econometr…Psychology: 0.23× its world share, 0 worksPsychologySocial Sciences: 0.02× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.7×. Every wedge is a field page.

Which keywords describe research at Sanofi (China)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Diabetes, Heart Failure, Clinical Guidelines, Cardiovascular Outcomes, Type 2 Diabetes and Cardiovascular Disease.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 37 words, with their numbers
  1. Glycemic Control8▲ 134×4 topics
  2. Insulin Therapy7▲ 156×3 topics
  3. Diabetes5▲ 27×5 topics
  4. Epidemiology5▲ 3.2×22 topics
  5. Heart Failure4▲ 28×3 topics
  6. Clinical Guidelines4▲ 41×3 topics
  7. Cardiovascular Outcomes4▲ 214×1 topic
  8. Type 2 Diabetes4▲ 52×1 topic
  9. Cardiovascular Disease4▲ 9.6×5 topics
  10. Type 1 Diabetes3▲ 95×2 topics
  11. Continuous Glucose Monitoring2▲ 150×1 topic
  12. Hypoglycemia2▲ 150×1 topic
  13. Obesity2▲ 7.3×4 topics
  14. Treatment2▲ 3.7×8 topics
  15. Inflammation2▲ 2.1×10 topics
  16. Clinical Trials2▲ 6.1×9 topics
  17. Cholesterol1▲ 27×3 topics
  18. Insulin Resistance1▲ 8.6×2 topics
  19. Atherosclerosis1▲ 12×3 topics
  20. Diagnosis1▲ 3.8×8 topics
  21. Genetics1▲ 4.9×5 topics
  22. Metabolic Syndrome1▲ 4.4×3 topics
  23. Pathogenesis1▲ 7.1×8 topics
  24. Proteasome Inhibitors1▲ 49×2 topics
  25. Catalysis1▲ 4.8×3 topics
  26. Diagnosis Criteria1▲ 95×1 topic
  27. Glucose Metabolism1▲ 33×1 topic
  28. International Myeloma Working Group1▲ 95×1 topic
  29. Lifestyle Intervention1▲ 38×1 topic
  30. Machine Learning1◆ 0.99×6 topics
  31. Medicinal Chemistry1▲ 11×2 topics
  32. Circular Economy1▲ 11×2 topics
  33. Deep Learning1◆ 0.90×3 topics
  34. Quality of Life1▲ 2.0×6 topics
  35. Cancer1▲ 2.1×8 topics
  36. Solvent Selection1▲ 138×1 topic
  37. Sustainable Chemistry1▲ 138×1 topic

Which research topics does Sanofi (China) publish most on?

By volume in 2022–2025: Diabetes Treatment and Management, Diabetes Management and Research, Multiple Myeloma Research and Treatments and Diabetes, Cardiovascular Risks, and Lipoproteins.

Diabetes Treatment and M…4Diabetes Treatment and Management: 4 fractional worksDiabetes Management and Research: 2 fractional worksMultiple Myeloma Research and Treatments: 1 fractional worksDiabetes, Cardiovascular Risks, and Lipoproteins: 1 fractional worksChemistry and Chemical E…1Chemistry and Chemical Engineering: 1 fractional worksDermatology and Skin Diseases: 1 fractional worksAsthma and respiratory diseases: 1 fractional worksDiabetes Management and Education: 1 fractional worksAcne and Rosacea Treatments and Effects: 0 fractional worksStatistical Methods in Clinical Trials: 0 fractional works
Endocrinology, Diabetes and MetabolismHematologyEnvironmental ChemistryDermatology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 4 works
  2. 2 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 2 works
  3. 3 Multiple Myeloma Research and Treatments Hematology 1 works
  4. 4 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 1 works
  5. 5 Chemistry and Chemical Engineering Environmental Chemistry 1 works
  6. 6 Dermatology and Skin Diseases Dermatology 1 works
  7. 7 Asthma and respiratory diseases Physiology 1 works
  8. 8 Diabetes Management and Education Endocrinology, Diabetes and Metabolism 1 works
  9. 9 Acne and Rosacea Treatments and Effects Dermatology 0 works
  10. 10 Statistical Methods in Clinical Trials Statistics and Probability 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.1%not open47.9%

World: 28% of research is openly available.

with international co-authors41.8%domestic only58.2%

World: 19% is written across borders.

How has Sanofi (China)'s research output changed?

Output in 2018–2022 was 55% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Shanghai

All research institutions in Shanghai

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.